Pay in 4 interest-free payments of $27.49 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
The coverage reflects the continuing debates on questions such as: BL what is an enrichment
Disabling injury may be overlooked
The Companion is lavishly illustrated throughout
upstart entrants
EAN: 9780071406703
Renal Cell Carcinoma Michael J. Kroes The coverage reflects the continuingWhile patients with metastatic renal cell carcinoma (mRCC) are now living longer with improved quality of life, the success of novel therapies for mRCC has created challenges for practicing oncologists. Many patients who initially respond to targeted therapies ultimately develop progressive disease due to acquired resistance to these agents. Additionally, some patients do not respond at all to any of the currently approved targeted agents,
US$ 12.70
US$ 89.99
US$ 19.99
US$ 24.99
US$ 24.99